Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria

Biochemical and Biophysical Research Communications
L ZhangR E Hancock

Abstract

Cationic peptides possessing antibacterial activity are virtually ubiquitous in nature, and offer exciting prospects as new therapeutic agents. We had previously demonstrated that such peptides could be produced by fusion protein technology in bacteria and several carrier proteins had been tested as fusion partners including glutathione-S-transferase, S. aureus protein A, IgG binding protein and P. aeruginosa outer membrane protein OprF. However these fusion partners, while successfully employed in peptide expression, were not optimized for high level production of cationic peptides (Piers, K., Brow, M. L., and Hancock, R. E. W. 1993, Gene 137, 7-13). In this paper we took advantage of a small replication protein RepA from E. coli and used its truncated version to construct fusion partners. The minimal elements required for high level expression of cationic peptide were defined as a DNA sequence encoding a fusion protein comprising, from the N-terminus, a 68 amino acid carrier region, an anionic prepro domain, a single methionine and the peptide of interest. The 68 amino acid carrier region was a block of three polypeptides consisting of a truncated RepA, a synthetic cellulose binding domain and a hexa histidine domain. The imp...Continue Reading

References

Dec 1, 1979·Journal of Bacteriology·R E Hancock, A M Carey
Jun 1, 1991·Antimicrobial Agents and Chemotherapy·R P DarveauC S Watkins
Jan 1, 1990·European Journal of Haematology·T GanzR I Lehrer
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B ChristensenD Mauzerall
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S Tabor, C C Richardson
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Zasloff
May 5, 1986·Journal of Molecular Biology·F W Studier, B A Moffatt
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·H Y AdariE K Spicer
Jul 1, 1985·Infection and Immunity·M E SelstedR I Lehrer
Mar 1, 1969·Archives of Biochemistry and Biophysics·S Panyim, R Chalkley
Jun 5, 1983·Journal of Molecular Biology·D Hanahan
Aug 1, 1993·Antimicrobial Agents and Chemotherapy·J E CallawayS P Lei
Jan 1, 1995·Advances in Microbial Physiology·R E HancockM Brown
Dec 1, 1996·Infection and Immunity·M GoughN M Kelly

❮ Previous
Next ❯

Citations

Jan 29, 2005·The Journal of Biological Chemistry·Yuxin ChenRobert S Hodges
Nov 5, 2014·BMC Research Notes·Sathiyamoorthy MeiyalaghanPhilippa J Barrell
Feb 24, 2006·Chemical Biology & Drug Design·Yuxin ChenRobert S Hodges
Feb 18, 2011·Bioengineered Bugs·Chun LiKlara Stensvåg
Sep 29, 2007·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Li WangYi Pang
Aug 30, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Q FengY Chen
Mar 31, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kuang-Ting ChengJya-Wei Cheng
Feb 4, 2009·Journal of Peptide Science : an Official Publication of the European Peptide Society·Verica VidovicSebastiaan Werten
Jan 17, 2007·Applied Microbiology and Biotechnology·Zi-Gang TianJian-Hua Wang
Nov 21, 2007·Applied Biochemistry and Biotechnology·Yun-Qi Wang, Ji-Ye Cai
Jul 8, 2009·Applied Microbiology and Biotechnology·Jian Feng LiShuang Quan Zhang
Mar 10, 2010·Biochemistry. Biokhimii︠a︡·A A VassilevskiE V Grishin
Sep 15, 2005·Applied Microbiology and Biotechnology·K M MorinC M Mello
Jan 20, 2006·FEMS Immunology and Medical Microbiology·Gediminas A BiziuleviciusVilhelmina Zukaite
Aug 1, 2008·Journal of Separation Science·Colin T Mant, Robert S Hodges
Apr 12, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R López-RojasJ Pachón
Nov 13, 2019·Protein Expression and Purification·Ligia Luz Corrales-GarcíaGerardo Corzo
Nov 4, 2000·Biochemical and Biophysical Research Communications·J H LeeS S Hong
Feb 27, 1999·Current Opinion in Immunology·R I Lehrer, T Ganz
Jul 15, 2006·Protein Expression and Purification·Marzena Pazgier, Jacek Lubkowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.